HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luis Correa-González Selected Research

188Re-anti-CD20 monoclonal antibody

1/2008Biokinetics and dosimetry of 188Re-anti-CD20 in patients with non-Hodgkin's lymphoma: preliminary experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luis Correa-González Research Topics

Disease

2Neoplasms (Cancer)
05/2014 - 02/2003
1Pain (Aches)
05/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2008
1Leukemia
01/2008
1Lymphoma (Lymphomas)
01/2008
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2008
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2008
1Carcinoma (Carcinomatosis)
02/2003
1Ascites
02/2003
1Neoplasm Metastasis (Metastasis)
02/2003
1Hepatocellular Carcinoma (Hepatoma)
02/2003

Drug/Important Bio-Agent (IBA)

2RadiopharmaceuticalsIBA
01/2008 - 02/2003
1Radioisotopes (Radionuclides)IBA
05/2014
1Monoclonal AntibodiesIBA
01/2008
1188Re-anti-CD20 monoclonal antibodyIBA
01/2008
1Biotin (Vitamin H)FDA Link
02/2003

Therapy/Procedure

2Therapeutics
05/2014 - 02/2003
1Aftercare (After-Treatment)
05/2014
1Radioimmunotherapy
01/2008